Emerging Therapies in Pulmonary Hypertension

Pulmonary hypertension (PH) is a progressive condition that requires new therapeutic strategies to manage. Emerging treatments like targeted vasodilators and combination therapies are improving patient prognosis. Advances in drug development are focused on enhancing pulmonary blood flow and reducing right heart strain.

  • Targeted vasodilators and combination therapies

  • Improving patient prognosis with new treatments

  • Advances in drug development for PH

  • Focus on reducing right heart strain

    Related Conference of Emerging Therapies in Pulmonary Hypertension

    May 14-15, 2025

    4th World Summit on COPD

    Barcelona, Spain
    June 24-25, 2025

    16th Annual Congress on Pulmonology & Respiratory Medicine

    Aix-en-Provence, France

    Emerging Therapies in Pulmonary Hypertension Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in